Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo
Parkinson’s disease (PD) is one of the most widespread neurodegenerative diseases. However, the currently available treatments could only relieve symptoms. Novel therapeutic targets are urgently needed. Several previous studies mentioned that protein tyrosine phosphatase 1B (PTP1B) acted as a negati...
Main Authors: | Chien-Wei Feng, Nan-Fu Chen, Te-Fu Chan, Wu-Fu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2020/8814236 |
Similar Items
-
Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
by: Tian Wang, et al.
Published: (2020-01-01) -
The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson's disease
by: Ailane, Sara
Published: (2012) -
Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
by: Yanqin Wang, et al.
Published: (2017-01-01) -
Therapeutic Effect of Modulating TREM-1 via Anti-inflammation and Autophagy in Parkinson’s Disease
by: Chien-Wei Feng, et al.
Published: (2019-08-01) -
Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
by: Sandeep More, et al.
Published: (2017-05-01)